Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia

Neuropsychopharmacology

Volumn 31, Issue 1, 2006, Pages 221-230

  Lahti, Adrienne C ^a,c   Weiler, Martin A ^a   Holcomb, Henry H ^a   Tamminga, Carol A ^b   Carpenter Jr , William T ^a   McMahon, Robert ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

ACC; Hippocampus; PET; Psychosis; rCBF; Schizophrenia

Indexed keywords

CORE BINDING FACTOR; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DELUSION; FEMALE; FRONTAL CORTEX; HALLUCINATION; HEBEPHRENIA; HIPPOCAMPUS; HUMAN; LANGUAGE DISABILITY; LIMBIC CORTEX; LIMBIC SYSTEM; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROBIOLOGY; PARIETAL LOBE; PATHOPHYSIOLOGY; POSITIVE SYNDROME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCANNING ELECTROCHEMICAL MICROSCOPY; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 32844461728     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300837     Document Type: Article

References (70)

1. Alain C, McNeely HE, He Y, Christensen BK, West R (2002). Neurophysiological evidence of error-monitoring deficits in patients with schizophrenia. Cereb Cortex 12: 840-846.
2. Andreasen NC, Rezai K, Alliger RJ, Swayze II VW, Flaum M, Kirchner P et al (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single- photon emission computed tomography and the Tower of London. Arch Gen Psychiatr 49: 943-958.
3. Benes FM, Todtenkopf MS, Logiotatos P, Williams M (2000). Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat 20: 259-269.
4. Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT (1997). Attentional impairments in deficit and nondeficit forms of schizophrenia. Am J Psychiatr 154: 363-370.
5. Bush G, Luu P, Posner MI (2000). Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4: 215-222.
6. Carter CS, MacDonald III AW, Ross LL, Stenger VA (2001). Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatr 158: 1423-1428.
7. Carter CS, Mintun M, Nichols T, Cohen JD (1997). Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am J Psychiatr 154: 1670-1675.
8. Cleghorn JM, Franco S, Szechtman B, Kaplan RD, Szechtman H, Brown GM et al (1992). Toward a brain map of auditory hallucinations. Am J Psychiatry 149: 1062-1069.
9. Devinsky O, Morrell MJ, Vogt BA (1995). Contributions of anterior cingulate cortex to behaviour. Brain 118(Part 1): 279-306.
10. Dierks T, Linden DE, Jandl M, Formisano E, Goebel R, Lanfermann H et al (1999). Activation of Heschl's gyrus during auditory hallucinations. Neuron 22: 615-621.
11. Ebmeier KP, Blackwood DH, Murray C, Souza V, Walker M, Dougall N et al (1993). Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients. Biol Psychiatry 33: 487-495.
12. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD (1996). Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 4: 223-235.
13. Friston KJ, Liddle PF, Frith CD, Hirsch SR, Frackowiak RS (1992). The left medial temporal region and schizophrenia. A PET study. Brain 115(Part 2): 367-382.
14. Gloor P (1990). Experiential phenomena of temporal lobe epilepsy. Facts and hypotheses. Brain 113(Part 6): 1673-1694.
15. Greicius MD, Krasnow B, Reiss AL, Menon V (2003). Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 100: 253-258.
16. Gur RE, Mozley PD, Resnick SM, Mozley LH, Shtasel DL, Gallacher F et al (1995). Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gen Psychiatr 52: 657-667.
17. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Part 4): 593-624.
18. Heckers S, Goff D, Schacter DL, Savage CR, Fischman AJ, Alpert NM et al (1999). Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch Gen Psychiatr 56: 1117-1123.
19. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ et al (1998). Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1: 318-323.
20. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA (2000). Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am J Psychiatr 157: 1634-1645.
21. Insausti R, Amaral DG, Cowan WM (1987). The entorhinal cortex of the monkey: II. Cortical afferents. J Comp Neurol 264: 356-395.
22. Jessen F, Scheef L, Germeshausen L, Tawo Y, Kockler M, Kuhn KU et al (2003). Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatr 160: 1305-1312.
23. Kaplan RD, Szechtman H, Franco S, Szechtman B, Nahmias C, Garnett ES et al (1993). Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET). Schizophr Res 11: 47-54.
24. Kawasaki Y, Maeda Y, Sakai N, Higashima M, Yamaguchi N, Koshino Y et al (1996). Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structures. Psychiatry Res 67: 49-58.
25. Kircher TT, Liddle PF, Brammer MJ, Williams SC, Murray RM, McGuire PK (2001). Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study 3. Arch Gen Psychiatr 58: 769-774.
26. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter Jr WT (1989). The schedule for the deficit syndrome: an instrument for research in schizophrenia 3. Psychiatr Res 30: 119-123.
27. Klemm E, Danos P, Grünwald F, Kasper S, Möller HJ, Biersack H (1996). Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression - a study with single photon emission computed tomography. Psychiatr Res 68: 1-10.
28. Kopp B, Rist F (1999). An event-related brain potential substrate of disturbed response monitoring in paranoid schizophrenic patients. J Abnorm Psychol 108: 337-346.
29. Lahti AC, Chen LW, Warfel D, Michaelidis T, Bartko JJ, Tamminga CA (1998). The factor structure for psychotic symptoms in inpatients with schizophrenia over three clinical states. Schizophr Res 29: 31.
30. Lahti AC, Holcomb HH, Gao XM, Tamminga CA (1999). NMDA-sensitive glutamate antagonism: a human model for psychosis. Neuropsychoparmacology 21: 158-169.
31. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995). Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6: 869-872.
32. Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter Jr WT (2001). Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatr 158: 1797-1808.
33. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M et al (2004). Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29: 171-178.
34. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA (2003). Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry 53: 601-608.
35. Lennox BR, Park SB, Jones PB, Morris PG, Park G (1999). Spatial and temporal mapping of neural activity associated with auditory hallucinations. Lancet 353: 644.
36. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS (1992). Patterns of cerebral blood flow in schizophrenia. Br J Psychiatr 160: 179-186.
37. Mathalon DH, Fedor M, Faustman WO, Gray M, Askari N, Ford JM (2002). Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol 111: 22-41.
38. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S et al (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatr 48: 830-843.
39. McGuire PK, Quested DJ, Spence SA, Murray RM, Frith CD, Liddle PF (1998). Pathophysiology of 'positive' thought disorder in schizophrenia. Br J Pschiatr 173: 231-235.
40. McGuire PK, Shah GM, Murray RM (1993). Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet 342: 703-706.
41. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA (2001). Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 11: 543-550.
42. Min SK, An SK, Jon DI, Lee JD (1999). Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatr Res 90: 159-168.
43. Musalek M, Podreka I, Suess E, Nutzinger D, Passweg V, Strobl R et al (1988). Neurophysiological aspects of auditory hallucinations). 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls - a preliminary report. Psychopathology 21: 275-280.
44. Musalek M, Podreka I, Walter H, Suess E, Passweg V, Nutzinger D et al (1989). Regional brain function in hallucinations: a study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls. Comp Psychiatr 30: 99-108.
45. Nordahl TE, Kusubov N, Carter C, Salamat S, Cummings AM, O'Shora-Celaya L et al (1996). Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology 15: 541-554.
46. Penfield W, Perot P (1963). The brain's record of auditory and visual experience: a final summary and discussion. Brain 86: 595-696.
47. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D et al (2002). A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatr 159: 227-237.
48. Ragland JD, Gur RC, Raz J, Schroeder L, Kohler CG, Smith RJ et al (2001). Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatr 158: 1114-1125.
49. 15O. Implementation and validation. J Nucl Med 24: 790-798.
50. Ranganath C, Yonelinas AP, Cohen MX, Dy CJ, Tom SM, D'Esposito M (2004). Dissociable correlates of recollection and familiarity within the medial temporal lobes. Neuropsychologia 42: 2-13.
51. Rolls ET (2000). Hippocampo-cortical and cortico-cortical back-projections. Hippocampus 10: 380-388.
52. Sabri O, Erkwoh R, Schreckenberger M, Cremerius U, Schulz G, Dickmann C et al (1997). Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics. J Nucl Med 38: 181-188.
53. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM et al (1991). Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatr 48: 618-624.
54. Schroder J, Buchsbaum MS, Siegel BV, Geider FJ, Lohr J, Tang C et al (1996). Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 19: 41-53.
55. Shenton ME, Dickey CC, Frumin M, McCarley RW (2001). A review of MRI findings in schizophrenia. Schizophr Res 49: 1-52.
56. Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK (2000). Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatr 57: 1033-1038.
57. Siegel Jr BV, Buchsbaum MS, Bunney Jr WE, Gottschalk LA, Haier RJ, Lohr JB et al (1993). Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatr 150: 1325-1336.
58. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S et al (1995). A functional neuroanatomy of hallucinations in schizophrenia. Nature 378: 176-179.
59. Suzuki M, Yuasa S, Minabe Y, Murata M, Kurachi M (1993). Left superior temporal blood flow increases in schizophrenic and schizophreniform patients with auditory hallucination: a longitudinal case study using 123I-IMP SPECT. Eur Arch Psychiatr Clin Neurosci 242: 257-261.
60. Szechtman H, Woody E, Bowers KS, Nahmias C (1998). Where the imaginai appears real: a positron emission tomography study of auditory hallucinations. Proc Natl Acad Sci USA 95: 1956-1960.
61. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN et al (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatr 49: 522-530.
62. Van Hoesen GW (1982). The parahippocampus gyrus: New observations regarding its cortical connections in the monkey. Trends Neurosci 5: 345-350.
63. Vogt BA, Finch DM, Olson CR (1992). Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 2: 435-443.
64. Walter H, Podreka I, Steiner M, Suess E, Benda N, Hajji M et al (1990). A contribution to classification of hallucinations. Psychopathology 23: 97-105.
65. Weiss AP, Heckers S (1999). Neuroimaging of hallucinations: a review of the literature. Psychiatr Res 92: 61-74.
66. Weiss AP, Schacter DL, Goff DC, Rauch SL, Alpert NM, Fischman AJ et al (2003). Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol Psychiatr 53: 48-55.
67. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992). Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatr 49: 959-965.
68. Woodruff P, Brammer M, Mellers J, Wright I, Bullmore E, Williams S (1995). Auditory hallucinations and perception of external speech. Lancet 346: 1035.
69. Yuasa S, Kurachi M, Suzuki M, Kadono Y, Matsui M, Saitoh O et al (1995). Clinical symptoms and regional cerebral blood flow in schizophrenia. Eur Arch Psychiatr Clin Neurosci 246: 7-12.
70. Zorrilla LT, Jeste DV, Brown GG (2002). Functional MRI and novel picture-learning among older patients with chronic schizophrenia: abnormal correlations between recognition memory and medial temporal brain response. Am J Geriatr Psychiatr 10: 52-61.